Welcome!

SDN Journal Authors: Yeshim Deniz, Liz McMillan, Elizabeth White, Pat Romanski, TJ Randall

News Feed Item

Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection

IBM Technical Computing & Software Defined Storage Technology Manages Growing Scale and Diversity of Molecular Profiling Data in Cancer Care

ARMONK, N.Y., Sept. 17 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced that Caris Life Sciences is using IBM technical computing and storage technology to accelerate the company's molecular profiling services for cancer patients. These services deliver critically important information to help oncologists develop tailored therapeutic plans for each patient's unique cancer, which could lead to better health outcomes and reduced costs to the healthcare system in general.

Today, optimal cancer care requires sophisticated integration of diverse molecular profiling technologies, which analyze the alterations in molecular signaling pathways in a patient's tumor to best match them to potential treatment options or clinical trials by sifting through patient case history treatments, clinical trial data, medical literature, and other emerging evidence. This poses information overload challenges for oncologists who need to make treatment decisions in real time. Today's clinicians need access to sophisticated big data infrastructure and analytical algorithms to optimize clinical decisions.

To help meet this need, Caris is using multiple technologies to develop world-class molecular profiling services that help doctors advance evidence-based, personalized treatment options for cancer patients. It has tested more than 65,000 cancer patients for 70 different molecular markers using multiple technology platforms. These markers are then correlated with 55 FDA-approved cancer therapies and hundreds of clinical trials agents. 

The Caris tumor profiling database is one of the largest datasets in the application of advanced molecular profiling technologies to support clinicians in delivering personalized treatment recommendations – or precision oncology.

"Widespread access to "Big Data" resources is revolutionizing how cancer is diagnosed and treated and requires sophisticated data management and computational capabilities for annotation and analysis," said George Poste, DVM, Ph.D., Vice Chairman, Caris Life Sciences. "Molecular profiling data will soon be measured in the terabyte per patient level. It also has to be stored for years and be organized in a manner that facilitates deep analytic evaluation and ensures data security."

Working with IBM and premier IBM Business Partner Re-Store, Caris has developed a scalable, data-aware and secure infrastructure with IBM systems and servers for complex molecular profiling analysis. This enhanced infrastructure leverages the broadest range of IBM technologies in the life sciences industry. With the support of IBM technical computing and software defined storage technology, Caris can now make recommendations on 55 potentially actionable drug to molecular target associations as a result of being able to profile both genomic and proteomic data– a significant increase over the current 19 therapeutic recommendations using genomic information alone.

By adding IBM Tivoli Storage Manager and code name Elastic Storage to its HPC environment, Caris is able to access and process massive amounts of data at a significantly faster pace.

"Precision cancer diagnosis and treatment requires the ability to process and analyze staggering amounts of genomic and other clinical data with scale and speed, and to accelerate this work, we need to provide clinicians and analysts with technical computing platforms," said Frank N. Lee, Ph.D., Lead Architect, Genomic Medicine, IBM. "IBM technology has helped Caris handle this data volume with greater speed, efficiency and scalability, and at the same time maintain the required security and reliability essential for handling medical and health data."

Learn more about this story on IBM's A Smarter Planet blog: http://ibm.co/1qQwJ9h.
View a video for more details on this story: http://bit.ly/1m8lo4E

About IBM 
Learn more about IBM life sciences at: ibm.com/lifesciences 
Learn more about IBM technical computing systems at: ibm.com/technicalcomputing

About Caris Life Sciences
Caris Life Sciences is a leading biosciences company focused on fulfilling the promise of precision medicine through quality and innovation.  As the first commercial mover in comprehensive molecular profiling in oncology, Caris Molecular Intelligence™ is an industry vanguard, with 65,000-plus patients profiled and counting. Ordered by nearly 7,000 oncologists in 63 countries, Molecular Intelligence correlates molecular data generated from a patient's tumor with biomarker/drug associations derived from clinical cancer literature. Using a variety of advanced and clinically-relevant technologies, Caris provides oncologists with the most clinically actionable information to help them personalize treatment for cancer patients. This multi-technology approach enables Caris to provide therapeutic guidance for 55 drug associations, compared to the 19 that can be found through use of next-generation sequencing alone. The company is also developing a series of blood tests based on its proprietary Carisome® TOP platform — a revolutionary blood-based testing technology for diagnosis, prognosis, and theranosis of cancer and other complex diseases. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Australia and other international markets. To learn more, please visit www.carislifesciences.com.

Media Contacts:

Christine Douglass
IBM Media Relations
415-545-6737
[email protected]

Chaiti Sen
IBM Media Relations
212-671-9525
[email protected]

David Patti
Caris Life Sciences Media Relations
908-421-5971
[email protected]

IBM Corporation logo

Video - https://www.youtube.com/watch?v=18Pi-twMGuU&feature=youtu.be   
Logo - http://photos.prnewswire.com/prnh/20090416/IBMLOGO

SOURCE IBM

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

CloudEXPO Stories
In very short order, the term "Blockchain" has lost an incredible amount of meaning. With too many jumping on the bandwagon, the market is inundated with projects and use cases that miss the real potential of the technology. We have to begin removing Blockchain from the conversation and ground ourselves in the motivating principles of the technology itself; whether it is consumer privacy, data ownership, trust or even participation in the global economy, the world is faced with serious problems that this technology could ultimately help us in at least partially solving. But if we do not unpack what is real and what is not, we can lose sight of the potential. In this presentation, John Bates-who leads data science, machine learning and AI in the Adobe Analytics business unit-will present his 4-prong model of the general areas where Blockchain can have a real impact and the specific use...
The benefits of automated cloud deployments for speed, reliability and security are undeniable. The cornerstone of this approach, immutable deployment, promotes the idea of continuously rolling safe, stable images instead of trying to keep up with managing a fixed pool of virtual or physical machines. In this talk, we'll explore the immutable infrastructure pattern and how to use continuous deployment and continuous integration (CI/CD) process to build and manage server images for any platform. Then we'll show how automate deploying these images quickly and reliability with open DevOps tools like Terraform and Digital Rebar. Not only is this approach fast, it's also more secure and robust for operators.
Cloud is the motor for innovation and digital transformation. CIOs will run 25% of total application workloads in the cloud by the end of 2018, based on recent Morgan Stanley report. Having the right enterprise cloud strategy in place, often in a multi cloud environment, also helps companies become a more intelligent business. Companies that master this path have something in common: they create a culture of continuous innovation. In his presentation, Dilipkumar Khandelwal outlined the latest research and steps companies can take to make innovation a daily work habit by using enterprise cloud computing. He shared examples from companies that have benefited from enterprise cloud computing and took a look into the future of how the cloud helps companies become a more intelligent business.
Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also received the prestigious Outstanding Technical Achievement Award three times - an accomplishment befitting only the most innovative thinkers. Shankar Kalyana is among the most respected strategists in the global technology industry. As CTO, with over 32 years of IT experience, Mr. Kalyana has architected, designed, developed, and implemented custom and packaged software solutions across a vast spectrum of environments and platforms. His current area of expertise includes hybrid, multi-cloud as-a-service strategies that drive digital and cognitive enterprises to operational excellence. Throughout his career, Mr. Kalyana has established himself as a brilliant strategist, respected technical advisor, renowned speaker, admired author, and insigh...
At CloudEXPO Silicon Valley, June 24-26, 2019, Digital Transformation (DX) is a major focus with expanded DevOpsSUMMIT and FinTechEXPO programs within the DXWorldEXPO agenda. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of business. Only 12% still survive. Similar percentages are found throughout enterprises of all sizes.